Literature DB >> 9826392

Phagocytic and tumor necrosis factor alpha response of human mast cells following exposure to gram-negative and gram-positive bacteria.

M Arock1, E Ross, R Lai-Kuen, G Averlant, Z Gao, S N Abraham.   

Abstract

Recent studies have implicated rodent mast cells in the innate immune response to infectious bacteria. We report that cord blood-derived human mast cells (CBHMC) obtained from culture of cord blood progenitors phagocytozed and killed various gram-negative and gram-positive bacteria and simultaneously released considerable amounts of tumor necrosis factor alpha. Overall, the extent of the endocytic and exocytic response of CBHMC correlated with the number of adherent bacteria. Thus, human mast cells are intrinsically capable of mediating microbial recognition and of actively contributing to the host defense against bacteria.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9826392      PMCID: PMC108768     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

Review 1.  Microorganisms and mediator release: new aspects in airway diseases.

Authors:  S Norn
Journal:  Agents Actions Suppl       Date:  1992

Review 2.  Cytokine production by mast cells and basophils.

Authors:  S J Galli; J R Gordon; B K Wershil
Journal:  Curr Opin Immunol       Date:  1991-12       Impact factor: 7.486

3.  Mast cell phagocytosis of FimH-expressing enterobacteria.

Authors:  R Malaviya; E A Ross; J I MacGregor; T Ikeda; J R Little; B A Jakschik; S N Abraham
Journal:  J Immunol       Date:  1994-02-15       Impact factor: 5.422

4.  Interleukin-4 promotes the development of tryptase and chymase double-positive human mast cells accompanied by cell maturation.

Authors:  H Toru; M Eguchi; R Matsumoto; M Yanagida; J Yata; T Nakahata
Journal:  Blood       Date:  1998-01-01       Impact factor: 22.113

5.  Mast-cell heterogeneity: functional comparison of purified mouse cutaneous and peritoneal mast cells.

Authors:  D He; S Esquenazi-Behar; N A Soter; H W Lim
Journal:  J Invest Dermatol       Date:  1990-08       Impact factor: 8.551

6.  Heterogeneity of mast cells at multiple body sites. Fluorescent determination of avidin binding and immunofluorescent determination of chymase, tryptase, and carboxypeptidase content.

Authors:  N Weidner; K F Austen
Journal:  Pathol Res Pract       Date:  1993-03       Impact factor: 3.250

7.  IL-6 production by rat peritoneal mast cells is not necessarily preceded by histamine release and can be induced by bacterial lipopolysaccharide.

Authors:  I Leal-Berumen; P Conlon; J S Marshall
Journal:  J Immunol       Date:  1994-06-01       Impact factor: 5.422

8.  Mast cell degranulation induced by type 1 fimbriated Escherichia coli in mice.

Authors:  R Malaviya; E Ross; B A Jakschik; S N Abraham
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

9.  Differentiation of human mast cells from bone-marrow and cord-blood progenitor cells by factors produced by a mouse stromal cell line.

Authors:  M Arock; F Hervatin; J J Guillosson; J M Mencia-Huerta; D Thierry
Journal:  Ann N Y Acad Sci       Date:  1994-05-28       Impact factor: 5.691

10.  Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells.

Authors:  S G el-Lati; C A Dahinden; M K Church
Journal:  J Invest Dermatol       Date:  1994-05       Impact factor: 8.551

View more
  25 in total

1.  Lipoteichoic acid improves the capability of mast cells in the host defense system against bacteria.

Authors:  Naoki Imajo; Daisuke Kurihara; Nobuyuki Fukuishi; Asumi Inukai; Shinobu Matsushita; Shingo Noda; Mako Toyoda; Mino Yoshioka; Hayato Teruya; Yumiko Nishii; Nobuaki Matsui; Masaaki Akagi
Journal:  Inflamm Res       Date:  2009-05-26       Impact factor: 4.575

2.  Infection of mast cells with live streptococci causes a toll-like receptor 2- and cell-cell contact-dependent cytokine and chemokine response.

Authors:  Elin Rönnberg; Bengt Guss; Gunnar Pejler
Journal:  Infect Immun       Date:  2009-11-23       Impact factor: 3.441

3.  The role of mast cells in bacterial enteritis.

Authors:  Melanie A Sherman
Journal:  Am J Pathol       Date:  2007-06-14       Impact factor: 4.307

4.  Mast cells kill Candida albicans in the extracellular environment but spare ingested fungi from death.

Authors:  Elisa Trevisan; Francesca Vita; Nevenka Medic; Maria Rosa Soranzo; Giuliano Zabucchi; Violetta Borelli
Journal:  Inflammation       Date:  2014-12       Impact factor: 4.092

5.  NOD1 and NOD2 Interact with the Phagosome Cargo in Mast Cells: A Detailed Morphological Evidence.

Authors:  Giuliano Zabucchi; Elisa Trevisan; Francesca Vita; Maria Rosa Soranzo; Violetta Borelli
Journal:  Inflammation       Date:  2015       Impact factor: 4.092

6.  The mast cell tumor necrosis factor alpha response to FimH-expressing Escherichia coli is mediated by the glycosylphosphatidylinositol-anchored molecule CD48.

Authors:  R Malaviya; Z Gao; K Thankavel; P A van der Merwe; S N Abraham
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

7.  New insights into the antimicrobial effect of mast cells against Enterococcus faecalis.

Authors:  Matthias Scheb-Wetzel; Manfred Rohde; Alicia Bravo; Oliver Goldmann
Journal:  Infect Immun       Date:  2014-08-11       Impact factor: 3.441

8.  Intracellular Staphylococcus aureus-induced NF-κB activation and proinflammatory responses of P815 cells are mediated by NOD2.

Authors:  Xuhua Xie; Lili Wang; Fengyun Gong; Chao Xia; Jia Chen; Ying Song; Aixia Shen; Jianxin Song
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-06-09

9.  Interferon-γ enhances both the anti-bacterial and the pro-inflammatory response of human mast cells to Staphylococcus aureus.

Authors:  Emily J Swindle; Jared M Brown; Madeleine Rådinger; Frank R DeLeo; Dean D Metcalfe
Journal:  Immunology       Date:  2015-10-05       Impact factor: 7.397

10.  Mast cells inhibit intramacrophage Francisella tularensis replication via contact and secreted products including IL-4.

Authors:  Jyothi M Ketavarapu; Annette R Rodriguez; Jieh-Juen Yu; Yu Cong; Ashlesh K Murthy; Thomas G Forsthuber; M Neal Guentzel; Karl E Klose; Michael T Berton; Bernard P Arulanandam
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-30       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.